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a b s t r a c t
Chronic low back pain is extremely common with a life time prevalence estimated at greater
than 70% [1]. Facet joint arthrosis is thought to be the causative aetiological substrate in
approximately 25% of chronic low back pain cases [2].
Facet joint injection is a routine intervention in the armamentarium for both the
diagnostic and therapeutic management of chronic low back pain. In fact, a study by Carrino
et al. reported in excess of 94,000 facet joint injection procedures were carried out in the US in
1999 [3].
Although generally considered safe, the procedure is not entirely without risk. Complica-
tions including bleeding, infection, exacerbation of pain, dural puncture headache, and
pneumothorax have been described.
We report a rare case of a 47-year-old female patient who developed a left L4/5 facet
septic arthrosis with an associated subdural empyema and meningitis following facet joint
injection. This case is unique, as to the best of our knowledge no other case of subdural
empyema following facet joint injection has been reported in the literature.
Furthermore this case serves to highlight the potential serious adverse sequelae of a
routine and apparently innocuous intervention. The need for medical practitioners to be
alert to and respond rapidly to the infective complications of facet joint injection cannot be
understated.
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A 47-year-old lady was admitted to her local hospital with back
pain, acute onset left-sided sciatica and left lower limb
weakness, 2-weeks following a lumbar left L4/5 facet joint
injection with local anaesthetic and steroid. Further historyspital Birmingham NHS Foundation Trust, B15 2GW Birmingham,
@googlemail.com (A.H.D. Silva), Swarupsinh.Chavda@uhb.nhs.uk
p. z o.o. All rights reserved.
Fig. 2 – Sagittal T2 (STIR) image of lumbosacral spine.
Subdural collection demonstrated extending from inferior
margin of L3 to S1.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 0 3 – 2 0 6204demonstrated that immediately following her facet joint
injection, she had developed some low-pressure headaches
worse on sitting up which had eventually settled.
Clinically these features most likely suggested a dural
puncture and CSF leak following the facet joint injection. This
symptomatology was subsequently replaced over the subse-
quent 2 weeks with features of meningism including neck
stiffness and photophobia. This patient had no previous
signiﬁcant medical history. She had no medical conditions
such as diabetes mellitus which predisposed her to infection.
1.2. Examination
Clinical examination was essentially unremarkable with
except of a diffuse weakness affecting her left lower limb
myotomes (MRC grading 4/5). There was no evidence of anal
or urethral sphincter (bowel/bladder) dysfunction.
1.3. Radiology
MRI of her spine demonstrated a subdural abscess collection
extending from the left L4/5 facet joint through the
paraspinal musculature and into the epidural and subdural
space (Figs. 1–3). Cranio-caudal extension was apparent
superiorly to the level of the L2/3 disc space and inferiorly to
the level of the L5/S1 disc space (Fig. 2). There was also
evidence of some collection tracking along the left S1 nerve
root on the left side (Fig. 3). The thecal sac was pushed
anterio-laterally by the collection with displacement of the
nerve roots of the cauda equine (Fig. 3). Diagnostically, this
was a case of a subdural abscess and meningitis following a
facet joint injection.
1.4. Chemistry and microbiology
Her inﬂammatory markers on admission demonstrated a CRP
of 240 with a white cell count of 15.5. Blood cultures
demonstrated a staphylococcal aureus species. A lumbar
puncture was performed which demonstrated purulent and
turbid cerebrospinal ﬂuid with gram positive cocci. CT-guided
aspiration of the left multi-loculated paraspinal collection wasFig. 1 – Sagittal T2 (STIR) image of lumbosacral spine.
Abnormal high signal intensity demonstrated in left L4/5
facet and paraspinal muscles.performed within 24 h of admission. Frank pus was drained.
All samples grew staphylococcal aureus species.
1.5. Therapy
The patient was initially started on treatment with empirical
antibiotics with intravenous meropenem and vancomycin,
which was subsequently converted to ciproﬂoxacin and
rifampicin following sensitivities. The total duration of
antibiotic therapy was for a period of 6-weeks. The patient
rapidly improved following a few days of antibiotics with
resolution of the left L5 radicular pain and mild left lower limb
weakness.Fig. 3 – Axial T2 image at L4/5 level. Subdural collection
again demonstrated. Also evident is abnormal high signal
intensity in left L4/5 facet joint and left paraspinal muscles.
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The concept of spinal facet joint culpability in the aetiology of
chronic back pain has circulated since the early twentieth
century. Goldwaith in 1911 described the role of the
lumbosacral zygoapophysial joints in the development of
back pain in the context of their traumatic displacement or
dislocation [4]. However, it was Ghormley's description in
1933 of the facet syndrome that clearly illustrated the
zygoapophysial joints as a potential cause of chronic low
back pain [5]. This model of facet pain was supported by
pathomorphological zygoapophysial joint examination un-
dertaken by Badgley in 1941 [6].
The ﬁrst objective demonstration of the facet joint as an
aetiological cause of low back pain came in 1963 when Hirsch
et al. revealed that injection of normal saline into facet joints
could reliably produce symptoms of low back pain [7]. This
work was expanded upon in the 1976, when Mooney and
Robertson began systematic studies ﬂuoroscopically conﬁrm-
ing that intra-articular facet joint injections of normal saline
provoked low back pain [8]. They also demonstrated that
injection of local anaesthetic into the provoked facets provided
relief of the symptoms [8].
Currently lumbar facet joint injection together with medial
branch nerve block form one of the principal pillars of
treatment in the management of chronic lower back pain.
Unquestionably the procedure itself is relatively quick and
generally safe. The main risks described with facet joint
injections include bleeding, dural puncture and CSF leak
headache, potential exacerbation of pain and of course
infection [9].
Systematic review of the literature with relevance to
serious infective complications yielded eight case reports
describing nine patients [10–17]. One report detailed a patient
who developed an isolated epidural abscess following facet
joint injection [10]. Another described a patient who developed
an isolated paraspinal abscess [11]. Two patients developed
septic arthritis together with a paraspinal abscess [12,13]. Two
patients developed meningitis in association with a paraspinal
abscess [14]. A further reported a patient with an epidural
abscess in association with a paraspinal abscess [15]. Another
reported development of infective endocarditis with a para-
spinal abscess [16]. Finally, one report documented a patient
with generalised sepsis leading to multiple organ failure and
death following a facet joint injection [17].
To the best of our knowledge there has been no previous
reported case of subdural empyema formation consequent to
facet joint injection in the literature. The unique aspect of the
case that we report is predicated on the fact that this patient
developed a subdural empyema. This is extremely unusual
given that the dura typically provides a robust barrier to the
potential spread of infection into the subarachnoid compart-
ment.
We surmise that there was an inadvertent dural breach at
the time of the facet joint injection with subsequent
translocation of skin surface micro-organisms from the needle
into the subdural CSF space. Indeed our patient described a
change in her usual symptomatology with the immediate
onset of a new pattern left L5 distribution radicular painfollowing the facet injection. We postulate that this change in
the pattern of pain actually epitomised direct needle trauma to
the left L5 nerve root at the time of the facet injection.
Methicillin sensitive staphylococcus aureus was identiﬁed
as the causative agent in the case that we report. In fact this
has been the predominant documented causative organism
with six out of the nine reported cases isolating it. Of the
remaining three cases, an organism could not be identiﬁed in
two and one grew staphylococcus epidermidis on culture.
This distribution of organisms is perhaps unsurprising
given that iatrogenic spinal infection following facet joint
injection would always likely be attributable to common skin
commensal organisms. However, it is interesting that Muffo-
letto et al. reported that Staphylococcus aureus was also the
most common organism identiﬁed in spontaneous haemato-
genous pyogenic facet joint infection [18].
The treatment of localised septic complications following
facet joint injection usually comprises a protracted course of
intravenous antibiotics with or without subsequent oral
therapy. A suggested duration of therapy of 6–8 weeks has
been recommended in the literature [13]. This treatment
strategy is often augmented with percutaneous aspiration of
any signiﬁcant paraspinal abscess component thereby reduc-
ing the overall reservoir of infection. Operative surgical
drainage is usually reserved for those cases of signiﬁcant
neurological compromise secondary to a compressive infec-
tive collection.
In the current case report, the patient was duly managed by
combined percutaneous aspiration of the paraspinal abscess
together with long term intravenous antibiotics. Although the
case that we report was managed entirely with a conservative
schema, review of the existing case reports revealed a trend
towards operative intervention.
Speciﬁcally of the nine patients who experience the
infective sequelae of facet joint injection, ﬁve received
operative abscess drainage with concomitant intravenous
antibiotic therapy. A single patient was treated with isolated
surgical abscess debridement and another treated with just
intravenous antibiotics. Finally, in the remaining two
patients the employed treatment modalities could not be
determined.
Although the reported number of cases is clearly insufﬁ-
cient to edict categorically the optimal treatment protocol of
the infective complications of facet joint injection, consider-
ation of the reported outcomes would suggest that there is a
role for both conservative and more aggressive surgical
treatment strategies.
Of the 6 previously reported cases in which surgical
treatment was identiﬁable, there were two adverse negative
outcomes. This included a catastrophic outcome of a patient
death and a patient left with residual neurological compro-
mise. Our patient made a good clinical recovery with no
residual neurological deﬁcit on a conservative treatment
regime.
In conclusion, prevention of development of infection post
facet joint injection should always be paramount when
considering any invasive treatment for facet pain syndrome.
This is best achieved by employing rigorous asepsis and
limiting both the frequency of injections, and the number of
simultaneous injections [17].
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most important prognostic factor is the timing of therapy
instigation relative to the onset of symptoms [19]. Interven-
tionists who treat lumbar facet pain syndrome should
appreciate that while facet joint injection is generally safe
there does exist a small but tangible risk of catastrophic
infective complications. Immediate diagnosis together with
rapid commencement of treatment with either non-surgical or
surgical abscess drainage and administration of antibiotics is
essential for good patient outcome.
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